{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:07:47Z","timestamp":1780592867352,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10072-020-04746-2","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T08:03:48Z","timestamp":1601625828000},"page":"2013-2020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ischemic stroke\/transient ischemic attack in adults with primary immune thrombocytopenia: a meta-analysis"],"prefix":"10.1007","volume":"42","author":[{"given":"Lishou","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2726-8843","authenticated-orcid":false,"given":"Huilin","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"issue":"10","key":"4746_CR1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper N, Ghanima W (2019) Immune thrombocytopenia. N Engl J Med 381(10):945\u2013955","journal-title":"N Engl J Med"},{"issue":"3","key":"4746_CR2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajh.21616","volume":"85","author":"DR Terrell","year":"2010","unstructured":"Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN (2010) The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol 85(3):174\u2013180","journal-title":"Am J Hematol"},{"issue":"2","key":"4746_CR3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1076029614545213","volume":"22","author":"J Mihalov","year":"2016","unstructured":"Mihalov J, Timarova G (2016) A seeming paradox: ischemic stroke in the context of idiopathic thrombocytopenic purpura. Clinical & Applied Thrombosis\/Hemostasis 22(2):115\u2013120","journal-title":"Clinical & Applied Thrombosis\/Hemostasis"},{"key":"4746_CR4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2016.01.044","volume":"362","author":"JC Furlan","year":"2016","unstructured":"Furlan JC, Fang J, Silver FL (2016) Outcomes after acute ischemic stroke in patients with thrombocytopenia or thrombocytosis. J Neurol Sci 362:198\u2013203","journal-title":"J Neurol Sci"},{"issue":"5","key":"4746_CR5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MOH.0b013e3282ab98c7","volume":"14","author":"PF Fogarty","year":"2007","unstructured":"Fogarty PF, Segal JB (2007) The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol 14(5):515\u2013519","journal-title":"Curr Opin Hematol"},{"key":"4746_CR6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.thromres.2019.04.016","volume":"178","author":"C Ekstrand","year":"2019","unstructured":"Ekstrand C, Linder M, Baricault B, Lafaurie M, Sailler L, Lapeyre-Mestre M, Kieler H, Moulis G, Bahmanyar S (2019) Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - results from two nationwide cohorts. Thromb Res 178:124\u2013131","journal-title":"Thromb Res"},{"issue":"4","key":"4746_CR7","first-page":"334","volume":"119","author":"W Jy","year":"1992","unstructured":"Jy W, Horstman LL, Arce M, Ahn YS (1992) Clinical significance of platelet microparticles in autoimmune thrombocytopenias. Journal of Laboratory & Clinical Medicine 119(4):334\u2013345","journal-title":"Journal of Laboratory & Clinical Medicine"},{"issue":"2","key":"4746_CR8","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.thromres.2012.11.021","volume":"131","author":"EM Sewify","year":"2013","unstructured":"Sewify EM, Sayed D, Abdel Aal RF, Ahmad HM, Abdou MA (2013) Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura. Thromb Res 131(2):e59\u2013e63","journal-title":"Thromb Res"},{"issue":"5","key":"4746_CR9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MOH.0b013e32832ea49c","volume":"16","author":"P Davizon","year":"2009","unstructured":"Davizon P, Lopez JA (2009) Microparticles and thrombotic disease. Curr Opin Hematol 16(5):334\u2013341","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"4746_CR10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jth.13940","volume":"16","author":"JS Chandan","year":"2018","unstructured":"Chandan JS, Thomas T, Lee S, Marshall T, Willis B, Nirantharakumar K, Gill P (2018) The association between idiopathic thrombocytopenic purpura and cardiovascular disease: a retrospective cohort study. Journal of Thrombosis & Haemostasis 16(3):474\u2013480","journal-title":"Journal of Thrombosis & Haemostasis"},{"issue":"4","key":"4746_CR11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/bjh.13787","volume":"174","author":"M N\u00f8rgaard","year":"2016","unstructured":"N\u00f8rgaard M, Cetin K, Maegbaek ML, Kristensen NR, Ghanima W, Bahmanyar S, Stryker S, Christiansen CF (2016) Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study. Br J Haematol 174(4):639\u2013642","journal-title":"Br J Haematol"},{"issue":"2","key":"4746_CR12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12185-010-0636-3","volume":"92","author":"C Enger","year":"2010","unstructured":"Enger C, Bennett D, Forssen U, Fogarty PF, McAfee AT (2010) Comorbidities in patients with persistent or chronic immune thrombocytopenia. Int J Hematol 92(2):289\u2013295","journal-title":"Int J Hematol"},{"issue":"7","key":"4746_CR13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3324\/haematol.2009.018390","volume":"95","author":"A Sarpatwari","year":"2010","unstructured":"Sarpatwari A, Bennett D, Logie JW, Shukla A, Beach KJ, Newland AC, Sanderson S, Provan D (2010) Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom general practice research database. Haematologica 95(7):1167\u20131175","journal-title":"Haematologica"},{"issue":"15","key":"4746_CR14","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Jama 283(15):2008\u20132012","journal-title":"Jama"},{"issue":"1","key":"4746_CR15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jebm.12141","volume":"8","author":"X Zeng","year":"2015","unstructured":"Zeng X, Zhang Y, Kwong JS et al (2015) The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med 8(1):2\u201310","journal-title":"J Evid Based Med"},{"key":"4746_CR16","unstructured":"Moga C, Guo B, Schopflocher D, Harstall C (2012) Development of a quality appraisal tool for case series studies using a modified Delphi technique. http:\/\/www.iheca\/documents\/Case%20series%20studies%20using%20a%20modified%20Delphi%20technique.pdf. Accessed 11 Feburary, 2020"},{"issue":"1","key":"4746_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","volume":"72","author":"VN Nyaga","year":"2014","unstructured":"Nyaga VN, Arbyn M, Aerts M (2014) Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health 72(1):39","journal-title":"Arch Public Health"},{"issue":"1","key":"4746_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1536867X0800800102","volume":"8","author":"RJ Harris","year":"2008","unstructured":"Harris RJ, Deeks JJ, Altman DG, Bradburn MJ, Harbord RM, Sterne JA (2008) Metan: fixed-and random-effects meta-analysis. Stata J 8(1):3\u201328","journal-title":"Stata J"},{"issue":"7414","key":"4746_CR19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Bmj 327(7414):557\u2013560","journal-title":"Bmj"},{"issue":"2","key":"4746_CR20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1(2):97\u2013111","journal-title":"Res Synth Methods"},{"issue":"9","key":"4746_CR21","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","volume":"23","author":"MJ Sweeting","year":"2004","unstructured":"Sweeting MJ, Sutton AJ, Lambert PC (2004) What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 23(9):1351\u20131375","journal-title":"Stat Med"},{"key":"4746_CR22","volume-title":"Applied methodology for evidence-based medicine","author":"T Zhang","year":"2012","unstructured":"Zhang T, Zhong W (2012) Applied methodology for evidence-based medicine. Central South University Press, Changsha, Hunan Province"},{"issue":"13","key":"4746_CR23","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1182\/blood-2010-10-312819","volume":"117","author":"M N\u00f8rgaard","year":"2011","unstructured":"N\u00f8rgaard M, Jensen AO, Engebjerg MC, Farkas DK, Thomsen RW, Cha S, Zhao S, S\u00f8rensen HT (2011) Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. Blood 117(13):3514\u20133520","journal-title":"Blood"},{"key":"4746_CR24","doi-asserted-by":"crossref","first-page":"907304","DOI":"10.1155\/2015\/907304","volume":"2015","author":"A Sinkovic","year":"2015","unstructured":"Sinkovic A, Majal M (2015) The impact of thrombocytopenia on outcome in patients with acute coronary syndromes: a single center retrospective study. Biomed Res Int 2015:907304","journal-title":"Biomed Res Int"},{"key":"4746_CR25","unstructured":"Moret C, Tichelli A, Wieland-Greguare-Sander A, Angelillo-Scherrer A, Rovo A (2017) Prevalence and risk factors for thrombosis in adult ITP patients. Haematologica 102 (supplement 2): 594"},{"issue":"7","key":"4746_CR26","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.08.005","volume":"22","author":"JJ Sico","year":"2013","unstructured":"Sico JJ, Phipps MS, Concato J, Wells CK, Lo AC, Nadeau SE, Williams LS, Peixoto AJ, Gorman M, Boice JL, Bravata DM (2013) Thrombocytopenia and in-hospital mortality risk among ischemic stroke patients. Journal of Stroke & Cerebrovascular Diseases 22(7):e99\u2013e102","journal-title":"Journal of Stroke & Cerebrovascular Diseases"},{"key":"4746_CR27","unstructured":"Ekstrand C, Baricault B, Linder M, et al. (2017) Prevalence of cardiovascular risk factors and incidence of venous and arterial thrombosis in non-splenectomized immune thrombocytopenia adult patients in sweden and france. results from two nationwide studies. Blood Conference: 59th Annual Meeting of the American Society of Hematology, ASH 130 (Supplement 1)"},{"issue":"4","key":"4746_CR28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3904\/kjim.2011.26.4.449","volume":"26","author":"YJ Yang","year":"2011","unstructured":"Yang YJ, Yun GW, Song IC, Baek SW, Lee KS, Ryu HW, Lee MW, Lee HJ, Yun HJ, Kim S, Jo DY (2011) Clinical implications of elevated antiphospholipid antibodies in adult patients with primary immune thrombocytopenia. Korean J Intern Med 26(4):449\u2013454","journal-title":"Korean J Intern Med"},{"issue":"4","key":"4746_CR29","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2141.2008.07228.x","volume":"142","author":"C Pierrot-Deseilligny Despujol","year":"2008","unstructured":"Pierrot-Deseilligny Despujol C, Michel M, Khellaf M, Gouault M, Intrator L, Bierling P, Godeau B (2008) Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Br J Haematol 142(4):638\u2013643","journal-title":"Br J Haematol"},{"issue":"5","key":"4746_CR30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9343(99)80342-8","volume":"98","author":"R Stasi","year":"1995","unstructured":"Stasi R, Stipa E, Masi M, Cecconi M, Scim\u00f2 MT, Oliva F, Sciarra A, Perrotti AP, Adomo G, Amadori S, Papa G (1995) Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 98(5):436\u2013442","journal-title":"Am J Med"},{"issue":"6","key":"4746_CR31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1365-2141.2003.04547.x","volume":"122","author":"AJ Neylon","year":"2003","unstructured":"Neylon AJ, Saunders PW, Howard MR, Proctor SJ, Taylor PR (2003) Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 122(6):966\u2013974","journal-title":"Br J Haematol"},{"issue":"3","key":"4746_CR32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.21061","volume":"83","author":"JJ Jimenez","year":"2008","unstructured":"Jimenez JJ, Jy W, Mauro LM, Horstman LL, Fontana V, Ahn YS (2008) Transendothelial migration of leukocytes is promoted by plasma from a subgroup of immune thrombocytopenic purpura patients with small-vessel ischemic brain disease. Am J Hematol 83(3):206\u2013211","journal-title":"Am J Hematol"},{"issue":"2","key":"4746_CR33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000098360","volume":"16","author":"E Kaya","year":"2007","unstructured":"Kaya E, Erkurt MA, Aydogdu I, Kuku I, Ozhan O, Oner RI, Ulutas O (2007) Retrospective analysis of patients with idiopathic thrombocytopenic purpura from eastern Anatolia. Med Prin Pract 16(2):100\u2013106","journal-title":"Med Prin Pract"},{"issue":"6","key":"4746_CR34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1538-7836.2008.02963.x","volume":"6","author":"L Bidot","year":"2008","unstructured":"Bidot L, Jy W, Bidot C Jr, Jimenez JJ, Fontana V, Horstman LL, Ahn YS (2008) Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis. Journal of Thrombosis & Haemostasis 6(6):913\u2013919","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"4746_CR35","doi-asserted-by":"crossref","unstructured":"Moulis G, Baricault B, Ekstrand C, et al. (2018) Risk factors of thrombosis in adults with primary immune thrombocytopenia. a french nationwide cohort study. Blood Conference: 60th Annual Meeting of the American Society of Hematology, ASH 132 (Suppl. 1)","DOI":"10.1182\/blood-2018-99-112506"},{"issue":"S1","key":"4746_CR36","first-page":"S217","volume":"18","author":"C Enger","year":"2009","unstructured":"Enger C, Bennett D, Forssen U, McAfee AT (2009) Risk of thromboembolic events among persons with chronic idiopathic thrombocytopenia purpura. Pharmacoepidem DRS 18(S1):S217","journal-title":"Pharmacoepidem DRS"},{"key":"4746_CR37","first-page":"963506","volume":"2009","author":"MA Feudjo-Tepie","year":"2009","unstructured":"Feudjo-Tepie MA, Le Roux G, Beach KJ, Bennett D, Robinson NJ (2009) Comorbidities of idiopathic thrombocytopenic purpura: a population-based study. Adv Hematol 2009:963506","journal-title":"Adv Hematol"},{"issue":"3","key":"4746_CR38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.20104","volume":"76","author":"LM Aledort","year":"2004","unstructured":"Aledort LM, Hayward CP, Chen MG, Nichol JL, Bussel J (2004) Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. Am J Hematol 76(3):205\u2013213","journal-title":"Am J Hematol"},{"key":"4746_CR39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.thromres.2018.10.017","volume":"172","author":"N Machin","year":"2018","unstructured":"Machin N, Ragni MV, Comer DM, Yabes JG (2018) Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: an NIS study. Thromb Res 172:80\u201385","journal-title":"Thromb Res"},{"issue":"6","key":"4746_CR40","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1182\/blood.V98.6.1760","volume":"98","author":"R Diz-K\u00fc\u00e7\u00fckkaya","year":"2001","unstructured":"Diz-K\u00fc\u00e7\u00fckkaya R, Hac\u0131hanefio\u011flu A, Yenerel M, Turgut M, Keskin H, Nal\u00e7ac\u0131 M, \u012anan\u00e7 M (2001) Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood 98(6):1760\u20131764","journal-title":"Blood"},{"issue":"6","key":"4746_CR41","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9610(02)01091-7","volume":"184","author":"M Gadenstatter","year":"2002","unstructured":"Gadenstatter M, Lamprecht B, Klingler A, Wetscher GJ, Greil R, Schmid T (2002) Splenectomy versus medical treatment for idiopathic thrombocytopenic purpura. Am J Surg 184(6):606\u2013609 discussion 609-610","journal-title":"Am J Surg"},{"issue":"5","key":"4746_CR42","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/bjh.12318","volume":"161","author":"KJ Kim","year":"2013","unstructured":"Kim KJ, Baek IW, Yoon CH, Kim WU, Cho CS (2013) Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies. Br J Haematol 161(5):706\u2013714","journal-title":"Br J Haematol"},{"issue":"8","key":"4746_CR43","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/jth.12636","volume":"12","author":"M Ruggeri","year":"2014","unstructured":"Ruggeri M, Tosetto A, Palandri F, Polverelli N, Mazzucconi MG, Santoro C, Gaidano G, Lunghi M, Zaja F, de Stefano V, Sartori R, Fazi P, Rodeghiero F, the Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Anemia and Thrombocytopenias Working Party. GIMEMA Study ITP0311 (2014) Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors. Journal of Thrombosis & Haemostasis 12(8):1266\u20131273","journal-title":"Journal of Thrombosis & Haemostasis"},{"issue":"1","key":"4746_CR44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0976-7800.179166","volume":"7","author":"S Khare","year":"2016","unstructured":"Khare S (2016) Risk factors of transient ischemic attack: an overview. J Mid-life Health 7(1):2\u20137","journal-title":"J Mid-life Health"},{"issue":"2","key":"4746_CR45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/STROKEAHA.108.521419","volume":"40","author":"C Weimar","year":"2009","unstructured":"Weimar C, Diener HC, Alberts MJ, Steg PG, Bhatt DL, Wilson PW, Mas JL, R\u00f6ther J, REduction of Atherothrombosis for Continued Health Registry Investigators (2009) The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for continued health (REACH) registry. Stroke 40(2):350\u2013354","journal-title":"Stroke"},{"issue":"4","key":"4746_CR46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0049-3848(93)90138-E","volume":"72","author":"YJ Lee","year":"1993","unstructured":"Lee YJ, Jy W, Horstman LL, Janania J, Reyes Y, Kelley RE, Ahn YS (1993) Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 72(4):295\u2013304","journal-title":"Thromb Res"},{"issue":"3","key":"4746_CR47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.04.032","volume":"23","author":"M Ichijo","year":"2014","unstructured":"Ichijo M, Ishibashi S, Ohkubo T, Nomura S, Sanjo N, Yokota T, Mizusawa H (2014) Elevated platelet microparticle levels after acute ischemic stroke with concurrent idiopathic thrombocytopenic purpura. Journal of Stroke & Cerebrovascular Diseases 23(3):587\u2013589","journal-title":"Journal of Stroke & Cerebrovascular Diseases"},{"issue":"4","key":"4746_CR48","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2141.2010.08234.x","volume":"150","author":"J Thachil","year":"2010","unstructured":"Thachil J, Callaghan T, Martlew V (2010) Thromboembolic events are not uncommon in patients with immune thrombocytopenia. Br J Haematol 150(4):496\u2013497","journal-title":"Br J Haematol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04746-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04746-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04746-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T10:46:08Z","timestamp":1723718768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04746-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,2]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4746"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04746-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,2]]},"assertion":[{"value":"28 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval from an ethics committee was not required because all data used in the present study were extracted from publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}